CAS RN: 1340553-59-4
Methyl 5-(2-Pyridyl)pyrazole-3-carboxylate
Product Availability
Choose a grade to view its available package options.
1 package records1 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260422 |
250mg / 1g / 5g |
Confirm by inquiry |
Shanghai | 5-7 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.25g, 1g, 5g
- Available purity: >97%
- Inventory rows with stock: 6
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1340553-59-4
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.25g |
-- |
2
In Stock
|
Beijing |
Inquiry |
| 0.25g |
>97% |
2
In Stock
|
Beijing |
Inquiry |
| 1g |
-- |
2
In Stock
|
Shenzhen |
Inquiry |
| 1g |
>97% |
2
In Stock
|
Shanghai |
Inquiry |
| 5g |
-- |
2
In Stock
|
Shenzhen |
Inquiry |
| 5g |
>97% |
2
In Stock
|
Shenzhen |
Inquiry |
1340553-59-4 / methyl 3-pyridin-2-yl-1H-pyrazole-5-carboxylate
Standard CAS: 1340553-59-4
Multi CAS: No
Basic Information
CAS
1340553-59-4
Multi CAS
No
Molecular Formula
C10H9N3O2
Molecular Weight
203.200000
Exact Mass
203.069477
SMILES
COC(=O)C1=CC(=NN1)C2=CC=CC=N2
InChI
InChI=1S/C10H9N3O2/c1-15-10(14)9-6-8(12-13-9)7-4-2-3-5-11-7/h2-6H,1H3,(H,12,13)
InChIKey
QBGTUSUZROECAN-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
15
Aromatic heavy atom count
11
Fraction Csp3
0.1
Rotatable bonds
2
H-bond acceptors
4
H-bond donors
1
Molar refractivity
53.16
TPSA
67.87
LogP / Solubility
WLOGP
1.26
MLOGP
1.11
XLogP3
1
Consensus LogP
1.12
Log S (ESOL)
-2.3
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.13
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.27
Class (SILICOS-IT)
Moderately soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.07
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5